The ethics of HIV "Cure" research: What can we learn from consent forms?

AIDS Research and Human Retroviruses

Volumn 31, Issue 1, 2015, Pages 56-63

  Henderson, Gail E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; GENE TRANSFER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; LANGUAGE; LATENT PERIOD; MEDICAL RESEARCH; POLICY; PRIORITY JOURNAL; RISK ASSESSMENT; STUDY DESIGN; ACQUIRED IMMUNODEFICIENCY SYNDROME; CLINICAL TRIAL (TOPIC); ETHICS; MEDICAL INFORMATION; METHODOLOGY; PROCEDURES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; CONSENT FORMS; HEALTH COMMUNICATION; HUMANS; RESEARCH DESIGN;

EID: 84937132239     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2014.0219     Document Type: Article

References (38)

1. The Forum HIV Cure Project: Forum for Collaborative HIV Research 2014
2. Volberding P: HIV cure: The target is clearer but not yet close. Ann Intern Med 2014;160:505-506
3. Lo B, Grady C, and the Working Group on Ethics of the International AIDS Society: Ethical considerations in HIV cure research: Points to consider. Curr Opin HIV AIDS 2013;8:243-249
4. Emanuel EJ, Wendler D, and Grady C: What makes clinical research ethical?. JAMA 2000;283:2701-2711
5. Shah SK, Persaud D, Wendler DS, et al.: Research into a functional cure for HIV in neonates: The need for ethical foresight. Lancet Infect Dis 2014;14:893-898
6. Evans D: What would you do to cure HIV?. [Internet]. May 25, 2011 [cited November 10, 2014]. Available from www .aidsmeds.com/articles/hiv-cure-ethics-2042-20510.shtml
7. Eyal N and Kuritzkes DR: Challenges in clinical trial design for HIV-1 cure research. Lancet 2013;382 (9903): 1464-1465
8. Sugarman J: HIV cure research: Expanding the ethical considerations. Ann Intern Med 2013;159:490-491
9. Dubé K, Henderson GE, and Margolis DM: Framing expectations in early HIV cure research. Trends Microbiol 2014;22:547-549
10. Tucker JD, Volberding P, Margolis DM, et al.: Words matter: Discussing research towards an HIV cure in research and clinical contexts. J AIDS 2014;67(3):e110-1
11. History and Mission: Forum for Collaborative HIV Research 2014
12. King NMP, Henderson GE, Churchill LR, et al.: Consent forms and the therapeutic misconception: The example of gene transfer research. IRB: Ethics Hum Res 2005;27: 1-8
13. Henderson GE, Wolf SM, Kuczynski KJ, et al.: The challenge of informed consent and return of results in translational genomics: E analysis and recommendations. J Law Med Ethics 2014;42(3):344-355
14. The SMART Study Group: Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: A randomized trial. Ann Intern Med 2008;149: 289-299
15. Burman W, Grund B, Neuhaus J, et al.: Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: Results of a randomized controlled trial. J Acquir Immune Defic Syndr 2008;49: 142-150
16. Routy JP, Boulassel MR, Nicolette CA, and Jacobson JM: Assessing risk of a short-term antiretroviral therapy discontinuation as a read-out of viral control in immune-based therapy. J Med Virol 2012;84:885-889
17. Dresser R: When Science Offers Salvation: Patient Advocacy and Research Ethics. Oxford University Press, Oxford, 2001
18. Daniels N: How to achieve fair distribution of ARTs in 3 by 5. Background paper for the consultation on equitable access to treatment and care for HIV/AIDS ( January 26-27, 2004). 2004
19. Macklin R: Ethics and equity in access to HIV treatment- 3 by 5 initiative. Background paper for the consultation on equitable access to treatment and care for HIV/AIDS ( January 26-27, 2004). 2004
20. Rennie S and Behets F: AIDS care and treatment in Sub-Saharan Africa: Implementation ethics. Hastings Center Rep 2006;36:23-31
21. WHO: Ethical issues raised by the HIV/AIDS epidemic. 2014
22. Rennie S, Sugarman J, and the HPTN Ethics Working Group: HIV prevention trials network ethics guidance for research. 2009
23. KingNMP:RAC oversight of gene transfer research:Amodel worth extending?. J Law Med Ethics 2002;30:381-389
24. Hug K and Hermerén G: Which patient groups should be asked to participate in first-in-human trials of stem-cellbased therapies?. J Clin Ethics 2012;23:256-271
25. Palpant NJ and Dudzinski D: Zinc finger nucleases: Looking toward translation. Gene Ther 2013;20:121-127
26. Chapman AR: Addressing the ethical challenges of firstin-human trials. J Clin Res Bioethics 2011;2:113
27. Peay HL and Henderson GE: What motivates participation in HIV cure trials?. A call for real-time assessment to improve informed consent. J Virus Erad 2015;1:51-53
28. Dresser R: First-in-human trial participants: Not a vulnerable population, but vulnerable nonetheless. J Law Med Ethics 2009;37:38-50
29. King NMP: Defining and describing benefit appropriately in clinical trials. J Law Med Ethics 2000;28:332-343
30. Pentz RD, White M, Harvey RD, et al.: Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials. Cancer 2012;118:4571-4578
31. Henderson GE, Churchill LR, Davis AM, et al.: Clinical trials and medical care: Defining the therapeutic misconception. PLoS Med 2007;4:e324
32. Anderson JA and Kimmelman J: Extending clinical equipoise to phase 1 trials involving patients: Unresolved problems. Kennedy Inst Ethics J 2010;20:75-98
33. London AJ, Kimmelman J, and Emborg ME: Research ethics. Beyond access vs. protection in trials of innovative therapies. Science 2010;328:829-830
34. Weinfurt KP: Varieties of uncertainty and the validity of informed consent. Clin Trials 2008;5:624-625
35. Kass NE: Early phase clinical trials: Communicating the uncertainties of magnitude of benefit and likelihood of benefit. Clin Trials 2008;5:627-629
36. Henrich TJ, Hanhauser E, Marty FM, et al.: Antiretroviralfree HIV-1 remission and viral rebound after allogeneic stem cell transplantation: Report of 2 cases. Ann Intern Med 2014;161:319-327
37. Burke W, Evans BJ, and Jarvik GP: Return of results: Ethical and legal distinctions between research and clinical care. Am J Med Genet Part C: Semin Med Genet 2014;166C:105-111
38. Wolf SM, Lawrenz FP, Nelson CA, et al.: Managing incidental findings in human subjects research: Analysis and recommendations. J Law Med Ethics 2008;36:219-248